Episode 213: Arun Ananth and Tom Gallo – Data As An Asset With Proscia’s Diagnostic Network
Today my guests are Arun Ananth, CCO and Tom Gallo, CFO from Proscia.
What we discuss with Arun and Tom:
- Introduction to Proscia’s Diagnostic Network
- Reshaping the economics of pathology
- Economic opportunities in digital pathology
- Data as an asset in biomarker discovery
- Clinical trials as use cases
- Compliance and security in digital pathology
- Pathology’s central role in treatment
- Accelerating digital adoption and ROI
- Patient benefits and clinical trials
- Risks and barriers in digital pathology
- Advice for labs considering digital pathology
- Market adoption and future vision
Links for this episode:
Pathologists’ Assistant Shadowing Network
Proscia Cements Leadership in Diagnostic Pathology with 400% Growth in Daily Cases
Rewiring the Laboratory’s Bottom Line: Moving Towards Digital Pathology as a Profit Center
People of Pathology Podcast:
Responses